Quantcast
Last updated on April 18, 2014 at 5:48 EDT

Latest Morphine Stories

2012-08-23 02:25:48

REDWOOD CITY, Calif., Aug. 23, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced dosing of the first patient in the third of three planned Phase 3 studies for ARX-01, the Sufentanil NanoTab PCA System, its novel sublingual patient-controlled analgesia (PCA) system. This third ARX-01 Phase 3 study is a...

2012-08-17 06:08:59

Overdose has surpassed car accidents as leading cause of death in Rhode Island, Connecticut A Rhode Island Hospital researcher has found that the use of electronic prescription drug monitoring programs (PMPs) may have a significant impact on the demand for drug treatment programs and how prescribers detect and respond to abuse of painkillers. The study by Traci C. Green, Ph.D., MSc, research scientist in Rhode Island Hospital's department of general internal medicine, is published online...

Serious Illness And Death Found In Children Who Were Given Codeine
2012-08-16 13:12:11

Connie K. Ho for redOrbit.com — Your Universe Online The Food and Drug Administration (FDA) recently stated that a few children who were given codeine, a pain reliever, after surgery may have developed serious breathing problems that lead to death. The FDA first learned about the issue from perusing articles in the New England Journal of Medicine in 2009 as well as the journal Pediatrics in 2012. According to My Health News Daily, the FDA stated that it would begin reviewing...

Heroin And Morphine Addiction Can Now Be Blocked
2012-08-16 07:17:36

Clinical trials possible within 18 months In a major breakthrough, an international team of scientists has proven that addiction to morphine and heroin can be blocked, while at the same time increasing pain relief. The team from the University of Adelaide and University of Colorado has discovered the key mechanism in the body's immune system that amplifies addiction to opioid drugs. Laboratory studies have shown that the drug (+)-naloxone (pronounced: PLUS nal-OX-own) will...

2012-08-08 06:23:49

ALLEGAN, Mich., Aug. 8, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for morphine sulfate 100ml/5% oral solution. Perrigo will commence shipment of the product immediately. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Morphine sulfate oral solution, a Schedule II controlled substance, is indicated for the relief of...

2012-08-01 23:02:31

Penn researcher calls for additional strategies to properly weigh benefits, risks of prescribing painkillers A new risk management plan from the U.S. Food and Drug Administration to help clinicians properly prescribe drugs with addiction potential aims to help reduce the growing epidemic of opioid abuse in the United States. With deaths associated with these drugs, often sold illegally, now reaching toward 14,000 each year — including the fatal shootings of two Philadelphia teenagers...

Group Asks FDA To Change Painkiller Labels
2012-07-26 07:34:01

Connie K. Ho for redOrbit.com — Your Universe Online A group of clinicians, researchers, and health officials recently submitted a petition requesting the U.S. Food and Drug Administration (FDA) to regulate labels on opioid painkillers in an effort to stop abuse of the drugs. In the petition, the authors describe how opioid labels are overly broad and simply state “moderate to severe pain.” “These overly broad indications imply a determination by FDA that they...

2012-07-24 11:14:33

Chronic exposure to dim light at night can lead to depressive symptoms in rodents -- but these negative effects can be reversed simply by returning to a standard light-dark cycle, a new study suggests. While hamsters exposed to light at night for four weeks showed evidence of depressive symptoms, those symptoms essentially disappeared after about two weeks if they returned to normal lighting conditions. Even changes in the brain that occurred after hamsters lived with chronic light at...

2012-07-24 02:27:39

BLUE BELL, Pa., July 24, 2012 /PRNewswire/ -- Relmada Therapeutics, a clinical-stage company developing novel therapies for the treatment of chronic pain today announced the initial closing of $3 million in gross proceeds in a Series A financing for which Laidlaw & Company (UK) Ltd. is the exclusive placement agent. Noteholders BioAdvance and Ben Franklin Technology Partners of Southeastern Pennsylvania, as well as, equity investor Wonpung Mulsan Co., Ltd, have converted their existing...

2012-07-11 10:23:47

CHPA commends U.S. Sens. Casey (D-PA) and Murkowski (R-AK) for introducing bill prohibiting the sale of OTC cough medicines containing dextromethorphan to minors WASHINGTON, July 11, 2012 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauds U.S. Sens. Bob Casey (D-PA) and Lisa Murkowski (R-AK) for introducing legislation to help combat teen cough medicine abuse. The Preventing Abuse of Cough Treatments (PACT) Act of 2012 would prohibit the sale...